ArticleBreast cancer research : BCR2009

Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer.

Mark D Pegram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.